![]() |
Device Closure or Antithrombotic Therapy After Cryptogenic Stroke in Elderly Patients With a High-Risk Patent Foramen Ovale
Pil Hyung Lee, Jung-Sun Kim, Jae-Kwan Song, Sun U. Kwon, Bum Joon Kim, Ji Sung Lee, Byung Joo Sun, Jong Shin Woo, Soe Hee Ann, Jung-Won Suh, Jun Yup Kim, Kyusup Lee, Sang Yeub Lee, Ran Heo, Soo Jeong, Jeong Yoon Jang, Jang-Whan Bae, Young Dae Kim, Sung Hyuk Heo, Jong S. Kim
J Stroke. 2024;26(2):242-251. Published online 2024 May 30 DOI: https://doi.org/10.5853/jos.2023.03265
|
Citations to this article as recorded by
Patent Foramen Ovale and Other Cardiopathies as Causes of Embolic Stroke With Unknown Source
Jong S. Kim
Journal of Stroke.2024; 26(3): 349. CrossRef Interaction between age and therapeutic approach on outcome in older patients with patent foramen ovale-associated stroke
Seyoung Jung, Byung Joo Sun, Soe Hee Ann, Jong Shin Woo, Jung-Sun Kim, Pil Hyung Lee
Revista Española de Cardiología (English Edition).2024;[Epub] CrossRef Patent foramen ovale in patients ≥60 with cryptogenic stroke—not a bystander: why diagnosis and closure matter?
Jerry Lorren Dominic, Sneha Annie Sebastian, Haris Paul, Joan Thomas Mathew, Vishal R Dhulipala
European Journal of Preventive Cardiology.2024;[Epub] CrossRef
|